High-resolution analysis of 3p deletion in neuroblastoma and differential methylation of the SEMA3B tumor suppressor gene

Cancer Genetics and Cytogenetics

Volumn 174, Issue 2, 2007, Pages 100-110

  Nair, Prakash N ^a   McArdle, Linda ^b   Cornell, John ^a   Cohn, Susan L ^c   Stallings, Raymond L ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b OUR LADY S CHILDREN S HOSPITAL   (Ireland)

^c UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; RETINOIC ACID; SEMAPHORIN; SEMAPHORIN 3B; UNCLASSIFIED DRUG;

ALLELE; ARTICLE; CANCER CELL CULTURE; CELL DIFFERENTIATION; CHROMOSOME 3P; CPG ISLAND; DNA METHYLATION; DNA MICROARRAY; GENE DELETION; GENE EXPRESSION; GENE LOCUS; GENE MAPPING; HISTOPATHOLOGY; HUMAN; HUMAN CELL; NEUROBLASTOMA; PATHOGENESIS; PATHOLOGY; PRIORITY JOURNAL; PROMOTER REGION; SYMPATHETIC NERVE; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE;

ADOLESCENT; ANTINEOPLASTIC AGENTS; AZACITIDINE; BASE SEQUENCE; CELL DIFFERENTIATION; CELL LINE; CELL LINE, TUMOR; CHILD; CHILD, PRESCHOOL; CHROMOSOME BREAKAGE; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 3; CPG ISLANDS; DNA METHYLATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; INFANT; MEMBRANE GLYCOPROTEINS; MOLECULAR SEQUENCE DATA; NEUROBLASTOMA; NUCLEIC ACID HYBRIDIZATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEMAPHORINS; TRETINOIN;

EID: 34247181069     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2006.11.017     Document Type: Article

References (27)

1. Brodeur G.M. Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer 3 (2003) 203-216
2. McArdle L., McDermott M., Purcell R., Grehan D., O'Meara A., Breatnach F., Catchpoole D., Culhane A.C., Jeffery I., Gallagher W.M., and Stallings R.L. Oligonucleotide microarray analysis of gene expression in neuroblastoma displaying loss of chromosome 11q. Carcinogenesis 25 (2004) 1599-1609
3. Vandesompele J., Van Roy N., Van Gele M., Laureys G., Ambros P., Heimann P., Devalck C., Schuuring E., Brock P., Otten J., Gyselinck J., De Paepe A., and Speleman F. Genetic heterogeneity of neuroblastoma studied by comparative genomic hybridization. Genes Chromosomes Cancer 23 (1998) 141-152
4. Breen C.J., O'Meara A., McDermott M., Mullarkey M., and Stallings R.L. Coordinate deletion of chromosome 3p and 11q in neuroblastoma detected by comparative genomic hybridization. Cancer Genet Cytogenet 120 (2000) 44-49
5. Spitz R., Hero B., Ernestus K., and Berthold F. Deletions in chromosome arms 3p and 11q are new prognostic markers in localized and 4s neuroblastoma. Clin Cancer Res 9 (2003) 52-58
6. Stallings R.L., Howard J., Dunlop A., Mullarkey M., McDermott M., Breatnach F., and O'Meara A. Are gains of chromosomal regions 7q and 11p important abnormalities in neuroblastoma?. Cancer Genet Cytogenetics 140 (2003) 133-137
7. Vandesompele J., Baudis M., De Preter K., Van Roy N., Ambros P., Bown N., Combaret V., De Preter K., Brinkschmidt C., Christiansen H., Combaret V., Lastowska M., Nicholson J., O'Meara A., Plantaz D., Stallings R., Brichard B., Van den Broecke De Bie S., De Paepe A., Laureys G., and Speleman F. Unequivocal delineation of clinicogenetic subgroups and development of a new model for improved outcome prediction in neuroblastoma. J Clin Oncol 23 (2005) 2280-2299
8. Bronner C.E., Baker S.M., Morrison P.T., Warren G., Smith L.G., Lescoe M.K., Kane M., Earabino C., Lipford J., and Lindblom A. Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature 368 (1994) 258-261
9. Latif F., Tory K., Gnarra J., Yao M., Duh F.M., Orcutt M.L., Stackhouse T., Kuzmin I., Modi W., and Geil L. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 260 (1993) 1317-1320
10. Ohta M., Inoue H., Cotticelli M.G., Kastury K., Baffa R., Palazzo J., Siprashvili Z., Mori M., McCue P., Druck T., Croce C.M., and Huebner K. The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell 4 (1996) 587-597
11. Tse C., Xiang R.H., Bracht T., and Naylor S.L. Human semaphorin 3B (SEMA3B) located at chromosome 3p21.3 suppresses tumor formation in an adenocarcinoma cell line. Cancer Res 62 (2002) 542-546
12. Xiang R.H., Hensel C.H., Garcia D.K., Carlson H.C., Kok K., Daly M.C., Kerbacher K., van den Berg A., Veldhuis P., Buys C.H., and Naylor S.L. Isolation of the human semaphorin III/F gene (SEMA3F) at chromosome 3p21, a region deleted in lung cancer. Genomics 32 (1996) 39-48
13. Chen H., He Z., Bagri A., and Tessier-Lavigne M. Semaphorin-neuropilin interactions underlying sympathetic axon responses to class 3 semaphorins. Neuron 21 (1998) 1283-1290
14. Shirvan A., Ziv I., Fleminger G., Shina R., He Z., Brudo I., Melamed E., and Barzilai A. Semaphorins as mediators of neuronal apoptosis. J Neurochem 73 (1999) 961-971
15. Tomizawa Y., Sekido Y., Kondo M., Gao B., Yokota J., Roche J., Drabkin H., Lerman M.I., Gazdar A.F., and Minna J.D. Inhibition of lung cancer cell growth and induction of apoptosis after reexpression of 3p21.3 candidate tumor suppressor gene SEMA3B. Proc Natl Acad Sci U S A 98 (2001) 13954-13959
16. Stallings R.L., Carty P., McArdle L., Mullarkey M., McDermott M., Breatnach F., and O'Meara A. Molecular cytogenetic analysis of recurrent unbalanced t(11;17)'s in neuroblastoma. Cancer Genet Cytogenetics 154 (2004) 44-51
17. Selzer R.R., Richmond T.A., Pofahl N.J., Green R.D., Eis P., Nair P., Brothman A.R., and Stallings R.L. Analysis of chromosome breakpoints in neuroblastoma at sub-kilobase resolution using fine-tiling oligonucleotide array CGH. Genes Chromosomes Cancer 44 (2005) 305-319
18. Stallings R.L., Nair P., Maris J.M., Catchpoole D., McDermott M., O'Meara A., and Breatnach F. High-resolution analysis of chromosomal breakpoints and genomic instability identifies PTPRD as a candidate tumor suppressor gene in neuroblastoma. Cancer Res 66 (2006) 3673-3680
19. Frommer M., McDonald L.E., Millar D.S., Collis C.M., Watt F., Grigg G.W., Molloy P.L., and Paul C.L. A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc Natl Acad Sci U S A 89 (1992) 1827-1831
20. Kuroki T., Trapasso F., Yendamuri S., Matsuyama A., Alder H., Williams N.N., Kaiser L.R., and Croce C.M. Allelic loss on chromosome 3p21.3 and promoter hypermethylation of semaphorin 3B in non-small cell lung cancer. Cancer Res 63 (2003) 3352-3355
21. Giannini G., Di Marcotullio L., Ristori E., Zani M., Crescenzi M., Scarpa S., Piaggio G., Vacca A., Peverali F.A., Diana F., Screpanti I., Frati L., and Gulino A. HMGI(Y) and HMGI-C genes are expressed in neuroblastoma cell lines and tumors and affect retinoic acid responsiveness. Cancer Res 59 (1999) 2484-2492
22. Alaminos M., Davalos V., Cheung N.K.V., Gerald W.L., and Esteller M. Clustering of gene hypermethylation associated with clinical risk groups in neuroblastoma. J Natl Cancer Inst 96 (2004) 1208-1219
23. Mosse Y.P., Greshock J., Margolin A., Naylor T., Cole K., Khazi D., Hii G., Winter C., Shahzad S., Asziz M., Biegel J.A., Weber B.L., and Maris J.M. High-resolution detection and mapping of genomic DNA alterations in neuroblastoma. Genes Chromosomes Cancer 43 (2005) 390-403
24. Yang Q., Zage P., Kagan D., Tian Y., Seshadri R., Salwen H.R., Liu S., Chlenski A., and Cohn S.L. Association of epigenetic inactivation of RASSF1A with poor outcome in human neuroblastoma. Clin Cancer Res 10 (2004) 8493-8500
25. Abe M., Ohira M., Kaneda A., Yagi Y., Yamamoto S., Kitano Y., Takato T., Nakagawara A., and Ushijima T. CpG island methylator phenotype is a strong determinant of poor prognosis in neuroblastomas. Cancer Res 65 (2005) 828-834
26. Hoebeeck J., Vandesompele J., Nilsson H., De Preter K., Van Roy N., De Smet E., Yigit N., De Paepe A., Laureys G., Pahlman S., and Speleman F. Von Hippel-Lindau tumor suppressor gene expression level has prognostic value in neuroblastoma. Int J Cancer 19 (2006) 624-629
27. Wang Q., Diskin S., Rappaport E., Attiyeh E., Mosse Y., Shue D., Seiser E., Jagannathan J., Shusterman S., Bansal M., Khazi D., Winter C., Okawa E., Grant G., Cnaan A., Zhao H., Cheung N.K., Gerald W., London W., Matthay K.K., Brodeur G.M., and Maris J.M. Integrative genomics identifies distinct molecular classes of neuroblastoma and shows that multiple genes are targeted by regional alterations in DNA copy number. Cancer Res 66 (2006) 6050-6062